INTRODUCTION
Oral submucous fibrosis (OSMF) is a chronic disease which is more commonly found in patients in the Asian subcontinent and the far east. 1 It is characterized by the progressive build up of constricting bands of collagen in the cheeks and adjacent structures of the mouth which can severely restrict mouth opening and tongue movement and cause problems with speech and swallowing. 2 The exact cause being unknown but chewing of betel quid as well as other areca nut containing products, excessive use of chilies and spices, vitamin and iron deficiency and poor nutrition has been suggested. However, the disease is considered to be multifactorial. 3 Epidemiological studies have provided substantial evidence of a close correlation between betel quid chewing and the incidence of OSMF, as well as highlighting the significant contribution of smoking and alcohol consumption to the malignant transformation of OSMF. Six betel quid constituents affect the metabolism of collagen. 4 Serum immunoglobulin levels, which are used as parameters to assess humoral immunity, still continue to be an area of intensive investigative research. The changes in serum immunoglobulin levels may start much before the actual clinical symptoms appear. In the present era, saliva which is much handy than serum is of utmost importance. Saliva secretion is said to be hampered by chewing mechanism. Increasing use of smokeless tobacco and the potential effects on mucosal defense proteins are well understood. Tobacco is composed of many pharmacological agents including nicotine and its major metabolite cotinine. Nicotine initially stimulates exocrine gland secretion followed by inhibition of secretion. 5 Absorption of nicotine is rapid and complete through the oral mucosa. Tobacco chewers have lower salivary flow rates than nonusers. 5 IgA is the main component of the adaptive immune system present in the saliva. It is also referred to as secretory IgA. Secretory IgA antibodies inhibit microbial adherence, colonization and penetration of mucosal surfaces, inhibit metabolic pathways, neutralize enzymes, viruses and toxins, mediate expulsion of plasmids and agglutination of microbes and inhibit the growth of certain organisms. 5 Plasma cells in close proximity to secretory epithelial cells secrete IgA. 6 Functional ability of secretory immune system is the major line of defense against mucosal pathogens. Smokeless tobacco reduces the cytotoxic lysis of tumor cells by macrophages in vitro, indicates that cell-mediated immunity is affected. Smokeless tobacco users having significantly lower salivary flow rate is due to negative effect of nicotine on exocrine gland secretion, which has an initial stimulatory effect followed by an inhibition of saliva flow. 5 Increased secretion of salivary IgA is likely to benefit the oral mucosa by preventing the disease.
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AIMS AND OBJECTIVES
The aim of present study was to assess the salivary IgA levels in tobacco chewers and patients with oral submucous fibrosis. A correlation of IgA levels with clinical progression of the disease is also attempted.
MATERIALS AND METHODS
The study group was divided into three groups: Patients were randomly selected from the outpatient department. In each case approximately 1.0 ml of unstimulated saliva was collected from each subject by expectoration into a sterile glass centrifuge tube. The samples were immediately frozen at -20°C, and maintained at that temperature until shortly before assay, when the samples were thawed at 37°C, and then immediately centrifuged at 12,000 rpm for 10 minutes and supernatant fluid was used for assay of IgA by Quantia IgA. Results were tabulated and subjected for statistical analysis.
RESULTS
The study comprised of 80 subjects. A total of 20 cases of OSMF, 40 smokeless tobacco users and 20 controls were studied. Maximum cases of OSMF were seen in males (80%) and rest females (Table 1) . Smokeless tobacco chewers had 97% of males (Table 1) . Clinical staging of OSMF 50% had stage I, 30% had stage II and 20% had stage III (Table 2) . On functional grading of the disease, 40% had stage III, 30% had stage II and stage I each ( Table 3 ). The mean salivary IgA of smokeless tobacco chewers was reduced when compared to the control and the difference was significant (Table 4) . OSMF patients had increased IgA levels when compared with the controls as well as the smokeless tobacco chewers; however, these differences were not significant (Table 4) .
DISCUSSION
Principal immunoglobulin in external secretions and in the entire body is IgA, and its role in protection against certain mucosal pathogens has been established. Secretory IgA antibodies inhibit microbial adherence, colonization and penetration of mucosal surfaces, inhibit metabolic pathways, neutralize enzymes, viruses and toxins, mediate expulsion of plasmids and agglutination of microbes and inhibit the growth of certain organisms.
5 S-IgA is the major form of IgA present in saliva and studies in rat salivary glands have showed that secretion of IgA is increased by stimuli from both parasympathetic and sympathetic nerves. 6 Proctor (2001) established that reflex salivary stimulation with tasteless piece of polythene tube stimulated the epithelial cell transcytosis of IgA and hence increased secretion of IgA into saliva. Salivary flow increased approximately ten-fold during the first period of mastication compared with resting. IgA concentration remained unchanged by chewing initially but progressively decreased in successive periods of chewing, still its concentration remained four-fold greater than salivary output during rest. The possible explanation for the decline in IgA in consecutive periods of chewing is that it represents a wash out of proteins accumulated in a glandular compartment during the period of rest. 6 Tobacco is composed of many pharmacological agents including nicotine and its major metabolite cotinine. Nicotine initially stimulates exocrine gland secretion followed by inhibition of secretion. 5 Absorption of nicotine is rapid and complete through the oral mucosa. Tobacco chewers have lower salivary flow rates than nonusers. 5 Stensons duct of parotid gland is longer and more convoluted than the more accessible submandibular, sublingual and minor salivary glands. Therefore, it is more likely that smokeless tobacco directly affects the secretory epithelial cells in the minor and submandibular and sublingual salivary glands which are responsible for producing and packaging secretory component into IgA-J chain complexes synthesized in plasma cells. The higher contribution (three to four-fold) of IgA from minor gland saliva than from parotid saliva and the relatively easier access of oral substances support the possibility of smokeless tobacco having an effect on minor salivary glands.
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Nicotine significantly reduces the secretory component, lactoferrin and lysozyme, also reducing the total cell numbers and their metabolic activity in smokeless tobacco users than nonusers. 5 This could be the reason that smokeless tobacco users have reduced IgA levels. The reason why OSMF patients have increased IgA levels needs to be answered. However, one possible reason could be that initially tobacco reduces but consecutively it increases the IgA levels in saliva. 5 Abrol BM (1977) reported increase in IgG in OSMF patients and IgA was found to be unaltered. He hypothesized that increased permeability leads to passive diffusion of IgG from vascular and extravascular compartment into the saliva. This may be suggestive of active inflammatory process. Increase in IgG and normal IgA levels is suggestive of only inflammation and no infection. 7 Sato K (1991) 11 estimated the S-IgA levels in patients having either lichen planus, leukoplakia and carcinoma in oral cavity who showed higher levels of S-IgA. The elevated levels of S-IgA in the saliva of these patients suggested that some local changes in the immunological competence might occur due to prolonged exposure to the antigen in the oral cavity. 8 This could be attributed to OSMF as well. We found an increase in S-IgA in the diseased individuals is suggestive of reactive phenomena trying to limit the disease. S-IgA which forms the major surface defense mechanism increases and tries to limit the disease progression. Nicotine increases the permeability of mucosal tissues thereby increasing its penetration. Secondary to this mucosa tries to defend the surface by increasing the defensive mechanism. Secretory epithelial cells increase the IgA secretion and also the diffusion of vascular IgA increases. Thereby we found an increase in S-IgA levels. We found decreased IgA in smokeless tobacco users. This is same as that reported in other studies.
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CONCLUSION
The present study was done to estimate the salivary IgA levels in oral submucous fibrosis patients and also in smokeless tobacco users. We found that smokeless tobacco users had reduced IgA levels than normal individuals and the OSMF patients had increased IgA levels secondary to disease onset. This is suggestive of some changes in the local immune response which tries to combat disease progress by building a barrier and preventing further changes. Anyways, study has to be done to evaluate the salivary IgA as a sensitive marker for therapeutic monitoring with the best known treatment for OSMF.
